Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 113 M112 M — Research & development 26 M27 M — Operating income 139 M88 M — Non-Operating Income, Total 36 M17 M — Interest expense, net of interest capitalized 2 M23 M — Non-Operating Income, excl. Interest Expenses -2 M-23 M — Unusual income/expense 36 M17 M — Pretax income 173 M86 M — Equity in earnings —— — Taxes 182 M32 M — Non-controlling/minority interest 26 M13 M — After tax other income/expense —— — Net income before discontinued operations -35 M41 M — Discontinued operations —— — Net income -35 M41 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -35 M41 M — Basic earnings per share (Basic EPS) —— — Diluted earnings per share (Diluted EPS) —0.26 — Average basic shares outstanding —158.7 M — Diluted shares outstanding —158.9 M — EBITDA 221 M169 M — EBIT 171 M115 M — Cost of revenue 659 M729 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 50 M54 M —